AGTRAP and glioblastoma: While no detailed biomarker studies in IDH wild-type GBM were available for comparison, studies in other types of solid cancer, such as hepatocellular carcinoma [6,39], cervix carcinoma [40] and tongue squamous cell carcinoma [41], showed that AGTRAP associated with the poor outcome of those patients.